High-dose methotrexate for the patient with osteogenic sarcoma.
D000284:Administration, Oral; D000293:Adolescent; D000666:Amphotericin B / Q000627:therapeutic use; D000855:Anorexia / Q000139:chemically induced; D001792:Blood Platelets; D001803:Blood Transfusion; D002177:Candidiasis / Q000188:drug therapy; D003875:Drug Eruptions / Q000209:etiology; D006801:Humans; D007263:Infusions, Parenteral; D007273:Injections, Intramuscular; D002955:Leucovorin / Q000008:administration & dosage / Q000627:therapeutic use; D008727:Methotrexate / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D009325:Nausea / Q000139:chemically induced; D012516:Osteosarcoma / Q000188:drug therapy* / Q000451:nursing / Q000601:surgery; D011030:Pneumothorax / Q000139:chemically induced; D013280:Stomatitis / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced
D000666:Amphotericin B; D002955:Leucovorin; D008727:Methotrexate